Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1141 studies found for:    ( "January 30, 2012" : MAX ) [FIRST-RECEIVED-DATE] AND (lymphoma OR CLL [CONDITION ]) AND NOT myeloma [CONDITION] | Open Studies
Found 1141 studies with search of:   ( "January 30, 2012" : MAX ) [FIRST-RECEIVED-DATE] AND (lymphoma OR CLL [CONDITION ]) AND NOT myeloma [CONDITION] | Open Studies

Modify this search

Recognized Terms and Synonyms:
lymphoma:   5535 studies
Lymphomatous:   15 studies
Lymphosarcoma:   1 studies
Chronic lymphocytic leukemia:   1106 studies
CLL:   338 studies
Lymphocytic Lymphoma:   716 studies
b cell leukemia:   15 studies
Chronic lymphoid leukemia:   6 studies
B-Cell Lymphocytic Leukemia:   1 studies
Chronic B-Lymphocytic Leukemia:   1 studies
Chronic lymphatic leukemia:   2 studies
Chronic Lymphoblastic Leukemia:   1 studies
leukemia chronic lymphocytic:   1 studies
Leukemia lymphocytic chronic:   3 studies
Small Cell Lymphoma:   1 studies
Kahler disease:   4 studies
myeloma:   2062 studies
Myelomatosis:   2 studies
plasma cell neoplasm:   338 studies
Related Terms:
Click on a related term to refine your search.
This will narrow your search by adding an additional search term.
If your search becomes too narrow (finds too few studies), broaden it by removing search terms with the Modify Search page.

B B-Cell
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
Bendamustine
Brentuximab
Brentuximab Vedotin
C CD19
CD30
Cell
B-Cell
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
cell lymphoma
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
mantle cell lymphoma
T-cell Lymphoma
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
mantle cell lymphoma
T-cell
T-cell Lymphoma
CHOP
cycle
Cyclophosphamide
D diffuse
Diffuse Large B-Cell Lymphoma
Lymphoma, Large B-Cell, Diffuse
DLBCL
doxorubicin
E Etoposide
F follicular
follicular lymphoma
H Hodgkin lymphoma
Non-Hodgkin's Lymphoma
I Ibrutinib
Immunoproliferative Disorders
L large
Diffuse Large B-Cell Lymphoma
Lymphoma, Large B-Cell, Diffuse
Lenalidomide
Lymphatic
Lymphatic Diseases
Lymphoma
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
cell lymphoma
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
mantle cell lymphoma
T-cell Lymphoma
follicular lymphoma
Hodgkin lymphoma
Non-Hodgkin's Lymphoma
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
Lymphoma, Non-Hodgkin
mantle cell lymphoma
Non-Hodgkin's Lymphoma
T-cell Lymphoma
Lymphoproliferative Disorders
M mantle
mantle cell lymphoma
N NHL
Non-
Lymphoma, Non-Hodgkin
Non-Hodgkin's Lymphoma
O Overall
Overall Response
P Prednisone
progression
Progression Free Survival
R Refractory
Relapsed
response rate
Rituximab
S survival
Progression Free Survival
T T-cell
T-cell Lymphoma
V vedotin
Brentuximab Vedotin
Vincristine